July 17, 2012
/PRNewswire-Asia/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio"), a leading
-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release its unaudited second quarter 2012 results on Wednesday, August 15, 2012 at
China Standard Time.
Following the earnings announcement, 3SBio's senior management will host a conference call on
Wednesday, August 15, 2012
China Standard Time (
US Eastern or
US Pacific) to discuss its unaudited second quarter 2012 results and recent business activity. The conference call may be accessed using the dial-in numbers below:
International toll-free dial-in:
Hong Kong: 800930346United States: 1-866-519-4004United Kingdom: 080-8234-6646
International toll dial-in:
65 6723 9381
Replay- Conference ID:
99264748A telephone replay will be available two hours after the call until August 22, 2012 at:International: 61-2-8235-5000
A live webcast of the conference will be available on the investor relations section of 3SBio's website at
A replay of the webcast will be available within one hour after the conclusion of the call.
About 3SBio Inc.
3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China. Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. With headquarters and GMP-certified manufacturing facilities in
, PRC, 3SBio employs over 800 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see
for more information.
Chief Financial Officer3SBio Inc.Tel: + 86 24 2581-1820
Director of Investor Relations3SBio Inc. Tel: + 852 8191-6991
SOURCE 3SBio Inc.